Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Aurinia’s Response to COVID-19

View

Latest News

June 1, 2020 • 12:00am EDT

Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Read Press Release View All News

May 26, 2020 • 12:00am EDT

Aurinia Completes Submission of New Drug Application to the U.S. Food & Drug Administration for Voclosporin for the Treatment of Lupus Nephritis

Read Press Release View All News

May 15, 2020 • 12:00am EDT

Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference

Read Press Release View All News